AlphAIAlphAI — Financial news for AI agents
tradingview.com$CLRO

ClearOne Received Notice of Delisting

Nasdaq notified ClearOne (CLRO) of a potential delisting due to insufficient stockholders' equity. The company plans to request a hearing by October 15, 2026, to contest the decision. Trading may be suspended if no hearing is requested.

Original reporting
tradingview.com
Published Oct 13, 2026, 10:03 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 13, 2026, 10:12 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
ClearOne Received Notice of Delisting — source image
Source · tradingview.com
Decision brief

The 30-second read

$CLROBearishHigh
01

Why it matters

The immediate market reaction is expected to be negative as investors price in the risk of suspension and loss of Nasdaq visibility. The uncertainty around a possible hearing adds volatility.

02

Market read

A primary corporate action for a micro‑cap stock that could lead to a sharp sell‑off if the delisting proceeds.

03

What to watch

Potential for a private placement or acquisition that could resolve the equity shortfall, which may mitigate downside.

Relevance 6/10Novelty 7/10Timing: pre‑market today

Background

ClearOne Inc. (CLRO) received a Nasdaq Capital Market delisting notice for failing to meet the $2.5M stockholders' equity threshold under Listing Rule 5550(b)(1). The company can request a hearing by Oct 15 to stay the suspension; otherwise trading may be halted on Oct 19.

Company-level read

Ticker impact

$CLROBearishHigh confidence
Context

Nasdaq issued a delisting notice to ClearOne for not meeting the $2.5M equity requirement, with a potential trading suspension on Oct 19 if no hearing is requested.

Expected impact

likely pressure as the market prices in the potential suspension and loss of Nasdaq listing

Evidence & confidence

Delisting notices are material corporate actions that typically trigger sell‑offs, especially for micro‑cap stocks with limited liquidity.

Market effects

Sector

Minimal; primarily affects the small‑cap technology segment where ClearOne operates.

Regional

Limited to U.S. markets; no broader regional effect.

Global

Low; the event is company‑specific and does not influence global markets.

Counterpoint

What could challenge this read

If ClearOne successfully appeals the delisting and secures a hearing, the stock could rebound on relief rally.

Key entities

  • company
    ClearOne Inc.

    Issuer of the delisting notice; ticker CLRO.

  • exchange
    Nasdaq

    Regulatory body issuing the delisting determination.

Read at source← All news

Related articles

$CLROMedAI 8/10

ClearOne (CLRO) Stock Soars Over 98% After Hours: Here's What You Need To Know ClearOne Shares Surge 98%

ClearOne (CLRO) shares jumped about 98% after hours after a majority stockholder, First Finance Ltd., approved by written consent the issuance of 12.5 million common shares tied to a merger, exceeding 20% of outstanding shares and triggering a change-of-control. The issuance takes effect 20 days after shareholder disclosure. ClearOne canceled First Finance warrants and signed CFO Simon Brewer to a new deal with $300,000 salary and 200,000 options.

benzinga.com
$CLROHighAI 9/10

ClearOne Stock Surges 30% On Cortigent Merger Agreement

ClearOne, Inc. (CLRO) shares rose 30.41% to $4.19 on Thursday after the company said it signed a definitive merger agreement under which Vivani Medical’s subsidiary Cortigent will become a wholly owned ClearOne unit. ClearOne plans a $10m–$15m concurrent financing. Cortigent develops implantable neurostimulation technologies.

rttnews.com
$CLROMedAI 8/10

ClearOne stock surges 50% on Vivani merger deal By Investing.com

ClearOne Inc (NASDAQ:CLRO) shares rose about 52.6% after it announced a definitive merger with Cortigent Inc, a Vivani Medical Inc (NASDAQ:VANI) subsidiary. Cortigent will become a wholly owned ClearOne unit; Vivani will receive 12.5M CLRO shares. Vivani would own 59.4%-67.5% post-close; ClearOne will rename Cortigent Holdings Inc, expected to trade as CRGT. An S-1 for $10M-$15M is planned; closing expected Q3 2026.

investing.com
$VANIMedAI 8/10

Vivani Announces Entry into Merger Agreement Between Wholly Owned Subsidiary Cortigent, Inc. and Nasdaq-listed ClearOne, Inc.

Vivani Medical (Nasdaq: VANI) said its subsidiary Cortigent will merge into ClearOne (Nasdaq: CLRO), with Cortigent becoming a wholly owned ClearOne unit. ClearOne plans a concurrent $10–15M financing via an S-1. Vivani will receive 12.5M ClearOne shares for 59.4%–67.5% ownership; ClearOne will rename to Cortigent Holdings (CRGT), expected to close Q3 2026.

manilatimes.net
$VANIMedAI 8/10

Vivani Medical, Inc.: Vivani Announces Entry into Merger Agreement Between Wholly Owned Subsidiary Cortigent, Inc. and Nasdaq-listed ClearOne, Inc.

Vivani Medical (Nasdaq: VANI) said its subsidiary Cortigent will merge into ClearOne (Nasdaq: CLRO) via a definitive agreement, making Cortigent a wholly owned ClearOne unit. ClearOne plans a concurrent $10m–$15m financing. Vivani will receive 12.5m ClearOne shares and own 59.4%–67.5%; the combined company will trade as CRGT, expected to close Q3 2026.

finanznachrichten.de